Nymox Pharmaceutical Corp Ret. on equity
What is the Ret. on equity of Nymox Pharmaceutical Corp?
The Ret. on equity of Nymox Pharmaceutical Corp is -683.11%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on NASDAQ compared to Nymox Pharmaceutical Corp
What does Nymox Pharmaceutical Corp do?
nymox pharmaceutical corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population. its lead drug candidate is fexapotide triflutate (nx-1207) that has completed phase iii clinical trials for the treatment of benign prostatic hyperplasia; and is in phase ii clinical trial for low grade localized prostate cancer, as well as is in preclinical studies for hepatocellular carcinoma. the company also develops and markets nicalert and tobacalert test strips that use urine or saliva to detect use of tobacco products. in addition, it offers alzheimalert, a proprietary urine assay that aids physicians in the diagnosis of alzheimer's disease. the company operates in canada, the united states, europe, and internationally. nymox pharmaceutical corporation was founded in 1989 and is headquartered in nassau, bahamas.
Companies with ret. on equity similar to Nymox Pharmaceutical Corp
- Dean Foods has Ret. on equity of -693.10%
- Dean Foods has Ret. on equity of -693.10%
- Dean Foods has Ret. on equity of -693.10%
- Verrica Pharmaceuticals Inc has Ret. on equity of -691.67%
- P2 Gold has Ret. on equity of -687.99%
- Euromax Resources has Ret. on equity of -684.33%
- Nymox Pharmaceutical Corp has Ret. on equity of -683.11%
- GPS Alliance has Ret. on equity of -680.00%
- Emerald Clinics has Ret. on equity of -678.22%
- HeraMED has Ret. on equity of -676.85%
- Nova Lifestyle Inc has Ret. on equity of -676.81%
- Symbol Mining has Ret. on equity of -670.64%
- Impelus has Ret. on equity of -670.18%